Cardiovascular Regeneration and Stem Cell Therapeutics
Cardiovascular regeneration and stem cell therapeutics focus on repairing damaged heart tissue and restoring cardiac function following injury or disease. Various stem cell types, including mesenchymal stem cells, cardiac progenitor cells, and induced pluripotent stem cells (iPSCs), are being investigated for cardiac repair. These therapies aim to promote angiogenesis, reduce inflammation, regenerate cardiomyocytes, and improve heart function after myocardial infarction and heart failure. Advances in tissue engineering, biomaterials, and bioengineered cardiac patches are enhancing the effectiveness of regenerative therapies. Cell-based treatments are also being combined with gene editing and growth factor delivery to improve therapeutic outcomes. Ongoing clinical trials continue to evaluate the safety, efficacy, and long-term benefits of stem cell-based cardiovascular therapies. Researchers are addressing challenges such as cell survival, engraftment, immune compatibility, and scalable manufacturing for clinical use. Overall, cardiovascular regeneration represents a promising approach for reducing the burden of heart disease and advancing next-generation regenerative medicine.
Related Conference of Cardiovascular Regeneration and Stem Cell Therapeutics
19th World Congress on Advances in Stem Cell Research and Regenerative Medicine
19th International Conference on Human Genomics and Genomic Medicine
Cardiovascular Regeneration and Stem Cell Therapeutics Conference Speakers
Recommended Sessions
- Adult Stem Cells and Tissue-Specific Regeneration
- Cardiovascular Regeneration and Stem Cell Therapeutics
- Embryonic Stem Cells and Pluripotent Stem Cells
- Hematopoietic Stem Cell Transplantation
- Induced Pluripotent Stem Cells (iPSCs)
- Mesenchymal Stem Cells: Biology and Therapeutic Applications
- Orthopedic Regenerative Medicine and Bone Tissue Engineering
- Regenerative Medicine: Current Advances and Future Perspectives
- Stem Cell Biology and Cellular Mechanisms
- Stem Cell Therapy for Neurological Disorders
Related Journals
Are you interested in
- Adult Stem Cells and Tissue-Specific Regeneration - Regenerative Medicine_2026 (France)
- Advanced Gene Therapeutics - Cell Signaling 2026 (France)
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Bioengineering Therapeutics - Cell Signaling 2026 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Cardiovascular Regeneration and Stem Cell Therapeutics - Regenerative Medicine_2026 (France)
- Cell Biology - Cell Signaling 2026 (France)
- Cell Culture and Bioprocessing - Cell Signaling 2026 (France)
- Cell Cycle/Proliferation - Cell Signaling 2026 (France)
- Cell Death and Viability - Cell Signaling 2026 (France)
- Cell Science and Stem Cell Research - Cell Signaling 2026 (France)
- Cellular Signaling - Cell Signaling 2026 (France)
- Cellular Therapies - Cell Signaling 2026 (France)
- Clinical Trials and Research in Stem Cell in Cancer Therapy - Cell Signaling 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Embryonic Stem Cells and Pluripotent Stem Cells - Regenerative Medicine_2026 (France)
- Epidermis Stem Cell & Cancer Epidemiology - Cell Signaling 2026 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Hematopoietic Stem Cell Transplantation - Regenerative Medicine_2026 (France)
- Human Gene Therapy - Cell Signaling 2026 (France)
- Immunotherapy - Cell Signaling 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) - Regenerative Medicine_2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells: Biology and Therapeutic Applications - Regenerative Medicine_2026 (France)
- Molecular Epigenetics - Cell Signaling 2026 (France)
- Nano-Therapy - Cell Signaling 2026 (France)
- Nanotechnology in Stem Cell - Cell Signaling 2026 (France)
- Orthopedic Regenerative Medicine and Bone Tissue Engineering - Regenerative Medicine_2026 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine - Cell Signaling 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Regenerative Medicine: Current Advances and Future Perspectives - Regenerative Medicine_2026 (France)
- Regulatory and Ethical Issues of Therapies. - Cell Signaling 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Regenerative Medicine_2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cell in Drug Development - Cell Signaling 2026 (France)
- Stem Cell Therapies - Cell Signaling 2026 (France)
- Stem Cell Therapy for Neurological Disorders - Regenerative Medicine_2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)
